DEFAZIO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 10.947
AS - Asia 3.627
EU - Europa 3.069
SA - Sud America 1.010
AF - Africa 162
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.826
Nazione #
US - Stati Uniti d'America 10.813
SG - Singapore 1.573
IT - Italia 1.210
BR - Brasile 825
CN - Cina 784
HK - Hong Kong 517
UA - Ucraina 298
DE - Germania 295
SE - Svezia 271
RU - Federazione Russa 244
FI - Finlandia 230
FR - Francia 194
VN - Vietnam 178
GB - Regno Unito 128
BD - Bangladesh 111
IN - India 111
CA - Canada 70
AR - Argentina 57
CI - Costa d'Avorio 49
IQ - Iraq 49
EC - Ecuador 42
BE - Belgio 40
TR - Turchia 37
IE - Irlanda 34
MX - Messico 32
PK - Pakistan 32
ID - Indonesia 31
ZA - Sudafrica 30
CO - Colombia 27
TW - Taiwan 23
JP - Giappone 22
SA - Arabia Saudita 22
PL - Polonia 21
ES - Italia 19
MA - Marocco 19
NL - Olanda 19
VE - Venezuela 19
IR - Iran 18
PH - Filippine 18
AE - Emirati Arabi Uniti 15
CL - Cile 14
CZ - Repubblica Ceca 14
TN - Tunisia 13
UZ - Uzbekistan 12
AT - Austria 11
MY - Malesia 10
EG - Egitto 9
JO - Giordania 9
KE - Kenya 9
LU - Lussemburgo 8
ET - Etiopia 7
JM - Giamaica 7
PE - Perù 7
PY - Paraguay 7
UY - Uruguay 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DZ - Algeria 6
KR - Corea 6
LB - Libano 5
NG - Nigeria 5
NP - Nepal 5
BH - Bahrain 4
BO - Bolivia 4
IL - Israele 4
KZ - Kazakistan 4
MD - Moldavia 4
PS - Palestinian Territory 4
SN - Senegal 4
SV - El Salvador 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
GE - Georgia 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CH - Svizzera 1
CU - Cuba 1
Totale 18.807
Città #
Fairfield 1.320
Woodbridge 1.039
Ashburn 868
Singapore 761
Houston 658
Jacksonville 647
Chandler 633
Seattle 531
San Jose 528
Hong Kong 517
Milan 466
Cambridge 433
Ann Arbor 423
Wilmington 389
Dallas 290
Rome 174
Beijing 166
Lawrence 165
Nanjing 165
Roxbury 165
Lauterbourg 164
Nyköping 149
Boardman 148
New York 141
Des Moines 110
Los Angeles 99
Columbus 93
Princeton 85
São Paulo 64
Ho Chi Minh City 63
Buffalo 57
Santa Clara 57
Helsinki 55
San Diego 54
Abidjan 49
Figino 47
Nanchang 46
Shenyang 45
Inglewood 43
Hebei 40
Bari 39
Turin 39
Chicago 37
Hanoi 36
Brooklyn 35
Brussels 34
Dublin 32
Naples 30
Jiaxing 29
Rio de Janeiro 25
Falkenstein 24
Nuremberg 23
Atlanta 22
Taipei 22
Baghdad 21
Munich 21
Frankfurt am Main 20
Quito 20
Chennai 19
London 19
Toronto 19
Tokyo 18
Warsaw 18
Montreal 17
San Mateo 17
Changsha 16
Johannesburg 16
Norwalk 16
San Francisco 16
Augusta 15
Belo Horizonte 15
Campinas 15
Brasília 14
Curitiba 14
Dhaka 14
Ribeirão Preto 14
Tianjin 14
Turku 14
Dearborn 13
Mexico City 13
Council Bluffs 12
Guangzhou 12
Orem 12
Phoenix 12
Pune 12
Tashkent 12
Brno 11
Guayaquil 11
Istanbul 11
Leawood 11
North Kansas City 11
Riyadh 11
Stockholm 11
Ardabil 10
Bologna 10
Fortaleza 10
Jakarta 10
Porto Alegre 10
Santo André 10
Boston 9
Totale 13.020
Nome #
Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile 220
Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs 204
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 192
Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings 175
A comparative study of primary and secondary hemifacial spasm 162
Antineuronal antibody status and phenotype analysis in Tourette's syndrome 161
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 159
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 153
Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population 152
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 150
No association between essential tremor and migraine: A case-control study 148
Personality disorders and somatization in functional and organic movement disorders 148
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 147
Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm 145
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 145
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 144
Antineuronal antibodies in cranial dystonia. 143
Onset and spread of dyskinesias and motor symptoms in Parkinson's disease 140
Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials 139
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study 139
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 139
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders 138
Camptocormia in Parkinson disease: an epidemiological and clinical study 136
Abnormal tactile temporal discrimination in psychogenic dystonia 135
A family study on primary blepharospasm 134
Relationship between eye symptoms and blepharospasm: a multicenter case-control study 133
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment 131
"Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report 130
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. 130
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 129
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort 129
The natural history of treated PD in an incident, community-based cohort: does the future begin? 129
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia 127
Post-streptococcal 'complex' movement disorders: unusual concurrence of psychogenic and organic symptoms 126
Headache in cranial and cervical dystonia 125
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 124
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia 122
Endocytosis of horseradish peroxidase by brain microvascular and umbilical vein endothelial cells in culture: an ultrastructural and morphometric study 121
La tossina botulinica nel recupero del piede equino-valgo da paralisi cerebrale infantile 121
EPIDEMIOLOGY OF PRIMARY BLEPHAROSPASM 120
Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing 118
Development and validation of a clinical guideline for diagnosing blepharospasm 117
Is increased blinking a form of blepharospasm? 117
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 116
Epidemiology of primary dystonia 116
Antinflammatory effects of rIFNb-1b in multiple sclerosis: longitudinal changes of the serum soluble Intercellular Adhesion Molecule-1 (sICAM-1), TNFa and T-cell subsets 116
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a 116
Psychiatric disorders in patients with essential tremor 115
Pain and motor complications in Parkinson's disease 114
The epidemiology of pain in Parkinson's disease 112
Disease modeling in functional movement disorders 112
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm 112
Pathophysiology of somatosensory abnormalities in Parkinson disease. 112
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? 111
Do primary adult-onset focal dystonias share aetiological factors? 110
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture 110
Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease 109
Epidemiology of primary and secondary dystonia 109
How pain arises in Parkinson's disease 109
Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study 109
The epidemiology of primary dystonia: current evidence and perspectives 108
Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm 108
Eye symptoms in relatives of patients with primary adult-onset dystonia 108
Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia 105
Influence of age on the association between primary hemifacial spasm and arterial hypertension 105
Fatigue in Parkinson's disease 105
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group 105
Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture 104
The influence of electroencephalographic focus laterality on efficacy of carbamazepine in complex partial and secondarily generalized tonic-clonic seizures 104
Ataxia in posterior circulation stroke: clinical-MRI correlations 104
Time processing in children with Tourette's syndrome 103
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia 103
Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials 103
Botulinum A toxin for the so-called apraxia of lid opening 103
Sleep and cranial dystonia 102
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria . 102
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder 102
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24) 102
Long-term assessment of the risk of spread in primary late-onset focal dystonia 101
Soluble adhesion molecules in Gilles de la Tourette's syndrome 101
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 101
Primary Cervical dystonia and scoliosis: a multicenter case-control study 101
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor 100
Primary hemifacial spasm and arterial hypertension: a multicenter case-control study 100
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia 100
Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening 100
Quality of sleep in primary focal dystonia: a case-control study 100
Mirror movements in patients with Parkinson's disease 100
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 99
Epidemiology of primary and secondary dystonia 98
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials 98
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 98
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia 98
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene 97
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 97
Menopause and menarche in patients with primary blepharospasm: an exploratory case-control study 96
Blepharospasm in bardet-biedl syndrome: a case report 96
Epidemiology of primary blepharospasm 94
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels 93
Tracing Sydenham's chorea: historical documents from a British paediatric hospital 91
Totale 12.040
Categoria #
all - tutte 73.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022949 45 68 5 35 58 96 29 47 104 90 163 209
2022/20231.499 272 122 46 172 221 204 7 148 236 5 36 30
2023/2024630 51 113 27 119 35 140 4 19 2 11 29 80
2024/20252.382 34 41 223 76 51 176 161 190 99 111 387 833
2025/20266.408 712 250 455 473 511 349 616 231 757 606 402 1.046
2026/2027350 350 0 0 0 0 0 0 0 0 0 0 0
Totale 19.270